Miraca Life Sciences launched the EoGenius test, which helps diagnose and monitor patients with eosinophilic esophagitis.
Here are four points:
1. The test helps clinicians differentiate between eosinophilic esophagitis and other similar pathologies, such as GERD.
2. It was developed by Marc E. Rothenberg, MD, PhD, at Cincinnati Children's Hospital.
3. EoGenius has been validated in both adult and pediatric populations.
4. Miraca Life Sciences provides anatomic pathology services, primarily in the fields of dermatology, hematology, gastroenterology, urology and breast health.